Pfizer and Valneva announce relaunch of Lyme disease vaccine trial
HQ Team December 6, 2023: Pfizer and Valneva SE announced that they have finalized enrolment in the VALOR Phase III trial of their.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team December 6, 2023: Pfizer and Valneva SE announced that they have finalized enrolment in the VALOR Phase III trial of their.
The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four.